ABVIX | DOXGX | ABVIX / DOXGX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 20 years | 2 years | - |
Gain YTD | 15.556 | 12.812 | 121% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2000000 | 2500 | 80,000% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 452M | 116B | 0% |
Annual Yield % from dividends | 1.28 | 1.45 | 88% |
Returns for 1 year | 20.24 | 20.85 | 97% |
Returns for 3 years | 9.05 | N/A | - |
Returns for 5 years | 37.06 | N/A | - |
Returns for 10 years | 47.89 | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
TSMDX | 15.98 | N/A | N/A |
Trillium ESG Small/Mid Cap Institutional | |||
MTCKX | 48.71 | -0.12 | -0.25% |
MFS Technology R1 | |||
JDEAX | 44.02 | -0.16 | -0.36% |
JPMorgan US Research Enhanced Equity A | |||
GGESX | 24.35 | -0.12 | -0.49% |
Nationwide Global Sust Eq Instl Svc | |||
BRXUX | 14.04 | -0.11 | -0.78% |
MFS Blended Research Intl Eq R4 |